top of page
Сортировка Медицина

TEMPUFEN solution for internal administration 50 ml

A tool that improves the activity of the CNS


Composition (in 1 ml solution) 
Active ingredients: 
γ-amino-phenyl fatty acid (GAPBA) 100 mg 
Pantothenic acid (vitamin B5) 1.2 mg 
Auxiliary substances:purified water, natural blackcurrant sweetener, sucralose, sodium hydroxide, potassium sorbate, sodium benzoate. 

Product Information 
Tempufen is a biologically active agent that improves the functioning of the central nervous system, has a neurometabolic, neuroprotective, neurotrophic, nootropic, anxiolytic effect, based on the properties of its components, biological activity and specific mechanism of action. 
γ-amino-phenyl fatty acid improves cerebral blood circulation, activates energy processes, tissue respiration and metabolism, accelerates the disposal of glucose and toxic substances. It helps to reduce and eliminate the feeling of excitement, tension, fatigue and fear, for this reason it can be used in the treatment of neuroses and before surgery. It improves the functional state of the brain and increases work capacity, reduces the occurrence of asthenia and vasovegetative symptoms (headache, heaviness in the head, sleep disturbance, irritability, emotional instability). Improves psychological indicators (attention, memory, speed and accuracy of sensorimotor reactions). When taken as a course of treatment, it increases mental and physical work capacity, strengthens memory, normalizes sleep, and improves the condition of patients with movement and speech disorders. It prolongs the latent period of nystagmus and shortens the duration and degree of manifestation. It has an antiaggregant and antioxidant effect. 
Vitamin B5 is a substance that ensures the normal functioning of the nervous system - neurotransmitters, 
strengthens the synthesis and metabolism of mediators and hormones. It is important for the normalization of the state of the nervous system and harmonious development in children and adolescents. Aging prevents dementia and Alzheimer's disease in older people. It improves the normal functioning of the brain, especially the ability to think. It activates the immune system by increasing the synthesis of antibodies. Provides all metabolic processes in the body. 

Instructions for use 
For children 
- Birth head injuries 
- Children born with hypoxia 
- Cerebral palsy in children 
- Mental retardation (mental, speech and motor) 
- Delay in physical development 
- Attention and memory disorders, impaired perception 
- Stuttering, tics 
- Enuresis 
For Adults 
- Head injuries, ischemic brain disease, brain stroke 
- Vascular diseases of the brain, especially in cases with headaches and dizziness 
- Acute and chronic cerebrovascular insufficiency 
- Asthenic and excited-neurotic states 
- Excitement, anxiety, tension, alertness and fear 
- Insomnia and "scary" dreams in the elderly 
- Polyneuritis and paresthesias 
- Memory and attention disorders 
- Meniere's disease, dizziness associated with vestibular analyzer dysfunction of various origins 
- Prevention of nausea and dizziness during kinetosis 
- Prevention of excited states before surgical operations and painful diagnostic examinations 
- As an auxiliary tool during the treatment of alcoholism (to eliminate psychopathological and somatovegetative disorders during abstinence syndrome). 

Hypersensitivity, liver failure, acute renal failure, pregnancy, lactation period. 
Method of use and dosage 
Tempufen solution is taken orally before meals. Before use, the drug can be dissolved in a little (10-20 ml) of water, milk or fruit juice. 
Use the following doses unless otherwise prescribed by a doctor


Single high dose limit: 150 mg for children under 8 years old, 250 mg for children 8-14 years old, 750 mg for adults, 500 mg for people over 60 years old. 
750 mg 3 times a day and 750 mg at night, provided that the daily dosage limit is gradually reduced to the usual limit for adults to reduce the abstinence syndrome on the first day of treatment of alcoholism. During the exacerbation of Meniere's disease, 750 mg 3-4 times a day for 5-7 days; when the severity of vestibular disorders decreases, 250-500 mg 3 times a day for 5-7 days and then 250 mg 2 times a day for 5 days. If the disease is mild, 250 mg twice a day for 5-7 days, then the dose limit is reduced to 250 mg once a day for 7-10 days. 250 mg 3 times a day for 12 days in order to prevent dizziness during disorders of vascular and traumatic origin of the vestibular analyzer. 250-500 mg 1 time 1 hour before the intended trip (has a dose-dependent effect) for the prevention of tremors.
Release form:Solution for internal administration, 50 ml. Packed in a cardboard box with 1 plastic vial, measuring syringe and leaflet. 
Producer: Lecifarma-Laboratorio Farmaceutico, Portugal. 

bottom of page